InVivo Therapeutics Holdings Corp (NVIVQ)

[DDobserver]

What I asked was the source of your assurance that this was not dead money for two years.


I am aware of the study parameters. I am aware that changes in the study parameters would cause major problems and time. If you have a source I would enjoy the read. Otherwise your assurance is nothing more than a speculation. My two years comes from the math. If it takes to the end of 2017 to enroll the remaining eight patients. Assume an additional sixth month follow up period without any negative results. Then add in three months for approval again without surprises and you are at October 2018.